| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6118599 | International Journal of Infectious Diseases | 2013 | 5 Pages |
Abstract
Finding CSF ADA greater than 6 U/l in patients with a meningeal syndrome strongly supports a diagnosis of TBM and permits the commencement of anti-tuberculous treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Lely Solari, Alonso Soto, Juan Carlos Agapito, Vilma Acurio, Dante Vargas, Tulia Battaglioli, Roberto Alfonso Accinelli, Eduardo Gotuzzo, Patrick van der Stuyft,